RecruitingNot ApplicableNCT06516939

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Sponsor

Shanghai Dermatology Hospital

Enrollment

28 participants

Start Date

Jun 10, 2024

Study Type

INTERVENTIONAL

Conditions

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Min Age: 18 YearsMax Age: 60 Years

Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3
No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out
Physical sunscreen should be strict during enrollment

Children
Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise
Patients with mental illness or cancer
Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months
Those who are allergic to basic fibroblast growth factor gel and its components
Acute dermatitis of the face and perifolliculitis

Interested in this trial?

Get notified about updates and connect with the research team.

DRUGbFGF

Half-face randomized control

DRUGBovine Basic Gel

Bovine Basic Gel

Shanghai Skin Disease Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06516939